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There are few published data on aldosterone and cortisol co-secreting adrenal tumours. Failure to
perform comprehensive preoperative endocrine investigations in patients with adrenal “incidentalomas”
or in those thought to be secreting only one hormone may account for this. Clinically patients with such
lesions may have evidence of hypertension and hypokalaemia with no features of cortisol excess.
Preoperative diagnosis of such lesions with accurate endocrinological work up is essential to prevent
adrenal insufﬁciency and haemodynamic crises following removal of such glands.
We present a series of 4 patients with co-secreting tumours treated by laparoscopic adrenalectomy
between September 2010 and March 2011. Our experience suggests that dual secretors are more
common than originally thought. A high index of suspicion and adequate endocrine work up is para-
mount in diagnosing such tumours and in experienced hands, laparoscopic adrenalectomy with
appropriate substitutive steroid cover is safe, feasible and curative for these functioning adrenal tumours.
 2012 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Adrenal adenomas are often discovered incidentally on
abdominal imaging that has been performed for reasons other than
suspected adrenal disease. Their incidence has been increasing
proportionally to the use and sensitivity of radiographic imaging
and is in the order of 4e6% of the imaged population.1-3 These
adenomas may be nonfunctional or hormonally active and malig-
nant or benign. In clinical practice, it is essential to characterize the
nature of these adenomas in order to treat them appropriately.
The optimal diagnostic approach to a patient with an adrenal
incidentaloma is well established [Fig.1]4 but not followed robustly.
It is reasonable to start with a careful history and physical exami-
nation, focussing on the signs and symptoms suggestive of adrenal
hyperfunction or malignant disease followed by imaging and
hormonal testing.
The optimal treatment approach for these lesions is still being
discussed. The general consensus is that small adrenal lesions with
features typical of an adenoma and without biochemical abnor-
mality can be safely left in-situ. Adrenal lesions withmanifestations
of hormonal excess need resection as do large [>4 cm] non-
functioning adrenal lesions as they are considered potentially
malignant.5 The treatment formalignant lesions depends on the cell
type, spread, and location of the primary tumour.6 Other consider-
ations include age, overall medical condition and patient anxiety.2,þ44 07958497278(mobile).
bo).
ciates Ltd. Published by Elsevier LtIn 1977, Hogan et al7 reported a patient with an adrenal
adenoma with concurrent production of cortisol and aldosterone.
Since then, there have been a few case reports but there has been
little published with regards to the surgical management of such
lesions. This paper reports a series of 4 cases of aldosterone and
cortisol co-secreting adrenal adenomas treated with a laparoscopic
adrenalectomy between September 2010 and March 2011.
2. Case 1
A 73 year old man presented to the accident and emergency
with a history of abdominal pain in January 2009. A computed
tomography (CT) scan of the abdomen revealed a 1.9 cm well cir-
cumscribed lesion at the medial aspect of the right adrenal gland. It
had Hounsﬁeld units of10 to5 thus consistent with a right sided
adrenal adenoma. On examination he did not have any features of
Cushing’s syndrome and his serum electrolytes were normal.
His past medical history included type 2 diabetes, hypertension,
a coronary artery bypass graft following a myocardial infarction in
2009 and chronic kidney disease stage 3. Medications at the time of
ﬁrst endocrine review were atenolol, doxazosin, frusemide, spi-
ronolactone, lisinopril, nifedipine, insulin, metformin and asprin. It
was arranged for him to have 24 h urine collection for catechol-
amines, overnight low dose dexamethasone suppression test
(LDDST) and an aldosterone:renin ratio. His medications were
stopped for the tests.
24 h urinary catecholamines were normal. The plasma aldos-
terone:renin ratio was high at 1300 suggesting hyperaldosteronismd. All rights reserved.
Fig. 1. Algorithm for the evaluation of an adrenal incidentaloma (4).
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had inadequate cortisol suppression. This indicated that he had
concurrent secretion of aldosterone and cortisol from his adrenal
adenoma.
A laparoscopic right adrenalectomy was performed in March
2011 with steroid cover. Histology conﬁrmed a completely excised
benign adrenocortical adenoma. Post operative recovery was
uneventful and the patient was discharged home at day 4.
3. Case 2
A 85 year old woman was referred to us following an incidental
ﬁnding of a right adrenal adenoma on CT performed for investi-
gation of weight loss and a possible abnormality on the chest Xray.
The left adrenal was normal. Past medical history included type 2
diabetes, hypertension and COPD. Medications included Doxazosin,
Fosinopril, Frusemide, Glicazide, Aspirin and Seretide, Salbutamol
and Spiriva inhalers.
Subsequent hormonal evaluation revealed an elevated plasma
renin:aldosterone ratio suggestive of hyperaldosteronism. Despite
the absence of full-blown clinical Cushing’s syndrome, further
investigations revealed suppressed basal ACTH levels, loss of
diurnal rhythm of cortisol, and failure to suppress cortisol on
LDDST, suggesting autonomous cortisol secretion by the tumour.
She underwent a right laparoscopic adrenalectomy in October
2010, with steroid cover. Histology conﬁrmed a 8.3 cm completely
excised benign adrenocortical adenoma. Post operative recovery
was uneventful and the patient was discharged home at day 5.
Complete clinical and biochemical remission of the disease was
observed postoperatively.
4. Case 3
A 77 year old femalewas referred from a district general hospital
for evaluation of a 12 cm adrenal mass discovered when a CT scan
was obtained to evaluate abdominal pain and rectal bleeding. Aswell as being a lifelong smoker, she also had a 10 year history of
hypertension and type 2 diabetes treated medically.
Endocrine evaluation revealed normal 24 h urinary catechol-
amines, raisedplasma renin:aldosterone ratio and failure to suppress
cortisol after a LDDST. Theseﬁndings suggested that both cortisol and
aldosterone were autonomously secreted from the tumour.
She underwent a right laparoscopic adrenalectomy in
September 2010 with steroid cover. Despite the size of the lesion,
conversion to open surgery was not required. Histology conﬁrmed
a 12 cm completely excised benign adrenocortical adenoma. She
was monitored routinely in the Intensive Care Unit and subse-
quently discharged to the ward. Post operative recovery was
complicated by a right lower lobe pneumonia which responded
well to intravenous antibiotics and chest physiotherapy. She was
discharged home 9 days after surgery.
5. Case 4
A 70 year old womanwas referred by the urologists following an
incidental ﬁnding of a mass adjacent to the upper pole of the right
kidney in keeping with an adrenal adenoma on an ultrasound
performed for investigation of suprapubic pain. Past medical
history included hypertension, hypercholesteraemia and bilateral
oophorectomy for ovarian cysts aged 48.
A subsequent CT revealed a 3.8 cm well circumscribed right
adrenal mass. This was of low density, with the unenhanced atten-
uation values ranging from 8 to 2. In the portal phase it has an
attenuation of up to 59. Based on its attenuation and features, this
was in keepingwith a benign adenoma. Furtherhormonal evaluation
showed normal urinary metanephrines, failure to suppress cortisol
adequately after a LDDST and a high plasma renin:aldosterone ratio.
She underwent an uneventful right laparoscopic adrenalectomy
in October 2010, with steroid cover. Histology conﬁrmed a 3.3 cm
completely excised benign adrenocortical adenoma. Post operative
recovery was uneventful and the patient was discharged home at 5
days.
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6.1. Imaging
The strength of any imaging test used to differentiate adrenal
lesions will depend on its sensitivity and speciﬁcity. CT without
intravenous contrast enhancement is usually sufﬁcient as the initial
study. If the adrenal mass is less than 10 Hounsﬁeld units [HU],
a diagnosis of adrenal adenoma can be made [71% sensitive, 98%
speciﬁc].8,9 All 4 of our patients had adrenal masses that were
homogenous and hypodensewith an unenhanced CTattenuation of
less than 10 HU consistent with the diagnosis of adrenal adenomas
Fig. 2.
If the adrenal mass is more than 10 HU, CT with intravenously
administered contrast should follow, and the washout calculated;
benign lesions typically demonstrate rapid washout of more than
50% [100% sensitive,100% speciﬁc]. In cases inwhich CT ﬁndings are
equivocal, chemical shift MRI can be performed. This reﬂects the
lipid content of tissues, with lipid-rich adenomas losing signal
intensity on out-of phase images.8,96.2. Hormonal testing
Although imaging phenotype is useful in predicting underlying
pathology, it does not predict endocrine function. FunctioningFig. 2. Pre and post contrast CT images for patient 4. CT without intravenous contrast-
3.8 cm adrenal mass <10 Hounsﬁeld units diagnostic of an adrenal adenoma (71%
sensitive, 98% speciﬁc). CT with intravenous contrast-rapid washout of >50% diag-
nostic of a benign adenoma (100% speciﬁc, 100% sensitive).incidental adrenal adenomas are usually clinically silent, therefore
biochemical investigation is warranted and evidence of hormonal
excess must be sought. The most common disease states caused by
functioning adenomas are Cushing’s syndrome due to excess
cortisol production and Conn’s syndrome due to excess aldosterone
production. Other secreted hormones include oestrogens, andro-
gens, and 17-hydroxyprogesterone. These often manifest clinically
and therefore do not require presumptive screening.
Approximately 5% of adrenal incidentalomas have been proved
to be phaeochromocytomas and this needs to be excluded in all
patients. The diagnosis is based on increased urinary catecholamine
excretion and the optimal diagnostic protocol is to measure both
free catecholamines and their metabolites the metanephrines.10
Clinically Silent Cushing’s Syndrome refers to patients with
autonomous cortisol secretion who do not have typical signs and
symptoms of hypercortisolism. Although the obvious stigmata of
Cushing’s syndrome are absent, these patients may have the
adverse effects of continuous, endogenous cortisol secretion,
including hypertension, diabetes mellitus, obesity and osteopo-
rosis.11e13
There is no consensus on the best evaluation for hyper-
cortisolism. The Endocrine Society Clinical Practice guidelines
published in 2008 suggest that the LDDST should be the ﬁrst line
screening test rather than urinary free cortisol which can be within
the normal range.14
The overnight test is a simple outpatient test. Various doses of
dexamethasone have been used, but 1 mg of dexamethasone is
usually given between 2300 and 2400 h, and cortisol is measured
between 0800 and 0900 h the following morning. Higher
doses [1.5e2 mg] do not signiﬁcantly improve the accuracy of the
test.15
Primary Aldosteronism refers to patients with an inappropri-
ately high aldosterone production, relatively autonomous from the
renin-angiotensin system, and non suppressible by sodium loading.
This inappropriate production of aldosterone causes cardiovascular
damage, suppression of plasma renin, hypertension, sodium
retention and potassium excretion that if prolonged and severe can
lead to hypokalaemia. These patients have a higher cardiovascular
morbidity and mortality than age- and sex-matched patients with
essential hypertension and the same degree of blood pressure
elevation and therefore normalization of circulating aldosterone
levels or mineralocorticoid receptor blockade is warranted in these
patients.16,17
The Endocrine Society Clinical Practice guidelines published in
2008 advocate screening for hyperaldosteronism in patients with
an adrenal incidentaloma and hypertension, citing a prevalence of
1.1e10%.18e23 Patients with an aldosterone producing adenoma
may have normal levels of potassium in the blood, and therefore
the measurement of potassium is not reliable in screening. The
recommended test is the plasma aldosterone:renin ratio, using
a sensitive renin assay and a diagnostic threshold of 20e40.24
6.3. Surgery
Laparoscopic adrenalectomy via the anterior transperitoneal
approach was performed in all 4 cases. Operative times ranged
from 70 to 125 min [average 100 min]. The harmonic scalpel was
used for dissection and minimal blood loss encountered. There
were no intraoperative complications.
None of the patients required conversion to an open procedure;
in patient 3 where the tumour measured 12 cm, the gland was
delivered by extending the optical incision to facilitate delivery
without fracture of the lesion and in patient 1 extensive adhesions
from previous surgery were dealt with laparoscopically. Length of
stay ranged from 4 to 9 days. The only post operative complication
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smoking history who developed a pneumonia that was treated
conservatively.
Laparoscopic adrenalectomy was ﬁrst performed and described
in the literature by Gagner in 1992. Since then, this technique has
becomemore andmorewidespread and there is general agreement
that laparoscopic surgery is superior to open surgery and is now the
’standard of care’. It is associated with reduced analgesic require-
ments, improved patient satisfaction, a shorter hospital stay, and
more rapid return to normal activities. It also yields the best
cosmetic and long term results. A meta-analysis of 2625 laparo-
scopic adrenalectomies showed a mortality of 0.2% 1 month after
surgery. Causes of death included haemorrhage, necrotizing
pancreatitis, pulmonary embolism, sepsis and cardiopulmonary
failure. The overall morbidity rate averaged 10%, with a higher rate
in phaeochromocytoma and Cushing’s syndrome.25 In the long
term, recurrence rates are not increased after laparoscopic
removal.26
Although the current literature supports the fact that laparos-
copy has replaced open surgery in the management of small and
medium sized adrenal lesions, limited experience exists with large
tumours [>10 cm]. It appears technical ability of the operator is
the overriding factor as opposed to tumour size in making this
decision.6.4. Peri and post operative care
Patients are at risk of an Addisonian crisis once the functioning
cortisol producing tumour is removed. This adrenal insufﬁciency is
caused by corticotropin suppression and adrenal cortical atrophy of
the contralateral adrenal gland.27,28 There are no widely accepted
guidelines for steroid substitutive therapy, and in our unit all
patients receive 100 mg Hydrocortisone in theatre and post oper-
atively, intravenous steroids are continued until the patients can
eat and drink. As the contralateral gland may take up to a year to
recover, oral longer term replacement with slow tapering is then
commenced, for example ﬂudrocortisone 50 mcg daily and oral
hydrocortisone 10, 5 and 5 mg daily.
Thromboprophylaxis is also given in the peri and post operative
period as these patients have an increased risk of thromboembolic
complications. This because of a hypercoagulable state resulting
from an increase in clotting factors such as factor VIII and von
Willebrand factor, and by impaired ﬁbrinolysis.29
Once discharged, patients are kept under close review by the
endocrine unit. The short synacthen test is used to establish adrenal
recovery and all patients in our series achieved endocrinological
cure.
Surgery almost universally cures the hypokalemia if present but
does not always cure the hypertension even in the setting of
normalization of hormone levels postoperatively. The reason some
patients have persistent hypertension is believed to be long-
standing hypertension, presence of coexisting hypertension, age
and a family history of hypertension.10,26,307. Conclusion
In conclusion, we believe that dual secreting adrenal
adenomas may be underdiagnosed due to lack of appropriate
endocrine work up before surgery. The numbers may be much
higher than previously thought. We recommend that adrenal
incidentalomas of any size should undergo hormonal testing
according to the established protocols. Phaechromocytomas,
hypercortisolism and hyperaldosteronism should be examined for
in all cases.Laparoscopic adrenalectomy is the treatment of choice for these
dual secretor adenomas and it is vital that following removal of the
functioning gland, the suppressed contralateral adrenal is covered
with steroid substitutive therapy until function has recovered in
order to prevent an Addisonian crisis.
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